top of page


Personalized Brachytherapy

Customized Image-guided Radiation therapy

Every patient. Every Treatment.

Starting first with cervical cancer.

Advaray™ is an early phase medical device research and development company based in Charlottesville, Virginia. Advaray™ is currently engaged in development of a hydrogel-based device to improve methods of image-guided pelvic brachytherapy. Our products will be inspired by unmet clinical needs in image-guided brachytherapy and designed to improve patient care from the perspectives of both patients and their physicians.

Funding Sources

National Cancer Center SBIR Development Center Logo

In addition to founder contributions, BrachyFoam has been fortunate to receive financial support in the form of grant funding from the National Cancer Institute and the Commonwealth Research Commercialization Fund. 

National Cancer Institute (NCI) Small Business Technology Transfer (STTR) Award (1R41CA203171-01A1): Self-expanding hydrogel for pelvic brachytherapy: a novel method for vaginal packing and customized radiation therapy. Awarded in 2017

Commonwealth Research Commercialization Fund STTR Matching Award (STTR18-002-LS): Development and validation of delivery system for commercialization of self-expanding hydrogel for pelvic brachytherapy. Awarded in 2018

National Cancer Institute (NCI) Small Business Technology Transfer (STTR) Award (2R42CA203171-02A1): Clinical validation and commercialization of a novel hydrogel-based vaginal packing system for pelvic brachytherapy. Awarded in 2019

Commonwealth Commercialization Fund (CCF) Award (CCF21-008-LS): Progress Toward Commercialization of a Novel Hydrogen-based Product for Pelvic Brachytherapy. Awarded in 2021

bottom of page